News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
59,086 Results
Type
Article (1315)
Company Profile (15)
Press Release (57756)
Section
Business (28188)
Career Advice (40)
Deals (4408)
Drug Delivery (1)
Drug Development (6492)
Employer Resources (3)
FDA (1055)
Job Trends (1526)
News (38271)
Policy (1895)
Tag
Academia (134)
Allergies (8)
Alliances (2225)
ALS (5)
Alzheimer's disease (67)
Antibody-drug conjugate (ADC) (15)
Approvals (1080)
Artificial intelligence (11)
Automation (1)
Bankruptcy (10)
Best Places to Work (1511)
Biosimilars (9)
Biotechnology (9)
Bladder cancer (19)
Brain cancer (3)
Breast cancer (48)
Cancer (302)
Cardiovascular disease (19)
Career advice (38)
CAR-T (7)
Cell therapy (35)
Cervical cancer (5)
Clinical research (5776)
Collaboration (38)
Compensation (44)
Complete response letters (2)
COVID-19 (156)
CRISPR (5)
C-suite (13)
Cystic fibrosis (4)
Data (317)
Depression (6)
Diabetes (19)
Diagnostics (596)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (8)
Drug pricing (4)
Duchenne muscular dystrophy (6)
Earnings (25252)
Editorial (2)
Employer branding (1)
Employer resources (3)
Events (6499)
Executive appointments (28)
FDA (1249)
Frontotemporal dementia (1)
Funding (53)
Gene editing (7)
Gene therapy (20)
GLP-1 (49)
Government (210)
Guidances (90)
Healthcare (1934)
IgA nephropathy (1)
Immunology and inflammation (8)
Indications (4)
Infectious disease (167)
Inflammatory bowel disease (12)
Influenza (5)
Intellectual property (8)
Interviews (3)
IPO (3530)
IRA (1)
Job creations (109)
Job search strategy (33)
Kidney cancer (1)
Labor market (2)
Layoffs (10)
Leadership (1)
Legal (290)
Liver cancer (7)
Lung cancer (49)
Lymphoma (19)
Management (1)
Manufacturing (19)
MASH (7)
Medical device (1575)
Medtech (1575)
Mergers & acquisitions (958)
Metabolic disorders (46)
Multiple sclerosis (7)
NASH (2)
Neurodegenerative disease (2)
Neuropsychiatric disorders (1)
Neuroscience (106)
NextGen: Class of 2025 (428)
Non-profit (229)
Obesity (23)
Opinion (2)
Ovarian cancer (13)
Pain (9)
Pancreatic cancer (16)
Parkinson's disease (9)
Partnered (3)
Patents (23)
Patient recruitment (8)
Peanut (6)
People (1791)
Pharmaceutical (4)
Pharmacy benefit managers (3)
Phase I (1434)
Phase II (2367)
Phase III (2359)
Pipeline (480)
Policy (3)
Postmarket research (233)
Preclinical (449)
Press Release (4)
Prostate cancer (7)
Radiopharmaceuticals (30)
Rare diseases (22)
Real estate (208)
Regulatory (1546)
Reports (4)
Research institute (112)
Resumes & cover letters (2)
Rett syndrome (2)
RSV (4)
Schizophrenia (12)
Series A (3)
Series B (5)
Service/supplier (1)
Sickle cell disease (3)
Spinal muscular atrophy (5)
Startups (140)
Stomach cancer (1)
Supply chain (2)
Tariffs (1)
Vaccines (50)
Venture capitalists (1)
Weight loss (8)
Women's health (4)
Worklife (2)
Date
Today (27)
Last 7 days (233)
Last 30 days (512)
Last 365 days (4475)
2025 (1646)
2024 (4822)
2023 (5397)
2022 (5846)
2021 (5983)
2020 (5340)
2019 (3856)
2018 (3153)
2017 (2765)
2016 (1890)
2015 (2597)
2014 (1952)
2013 (1281)
2012 (1518)
2011 (1633)
2010 (1432)
Location
Africa (36)
Alabama (5)
Alaska (2)
Arizona (13)
Asia (4101)
Australia (410)
California (928)
Canada (218)
China (83)
Colorado (42)
Connecticut (28)
Delaware (29)
Europe (7152)
Florida (147)
Georgia (43)
Idaho (1)
Illinois (57)
India (2)
Indiana (64)
Iowa (1)
Japan (21)
Kansas (54)
Kentucky (2)
Louisiana (4)
Maine (10)
Maryland (108)
Massachusetts (601)
Michigan (26)
Minnesota (58)
Missouri (4)
Montana (3)
Nevada (8)
New Hampshire (9)
New Jersey (308)
New York (189)
North Carolina (110)
Northern California (430)
Ohio (21)
Oklahoma (1)
Pennsylvania (179)
South America (80)
South Carolina (3)
Southern California (341)
Tennessee (13)
Texas (181)
United States (3295)
Utah (31)
Virginia (9)
Washington D.C. (1)
Washington State (67)
Wisconsin (2)
59,086 Results for "82".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kamari Pharma Announces Presentations at the 82nd Annual Meeting of the Society for Investigative Dermatology and the International Pachyonychia Congenita Consortium Symposium
May 8, 2025
·
4 min read
Press Releases
Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025
April 15, 2025
·
7 min read
Press Releases
Neurological Biomarkers Market Size to Hit USD 31.82 Billion by 2034
February 20, 2025
·
1 min read
Press Releases
Asthma and COPD Drugs Market Size to Hit USD 59562.82 Million by 2034
February 26, 2025
·
1 min read
Press Releases
Pharmaceutical Market Size to Surpass USD 2.82 Trillion by 2033
January 29, 2025
·
1 min read
Press Releases
EnChannel Medical Raises $82.2M in Oversubscribed Series-B Financing to Advance Full-Chamber 5D Atrial Fibrillation Mapping and Personalized Pulsed-Field Ablation Therapy
May 1, 2025
·
2 min read
Press Releases
Biological Safety Testing Services Market Size to Hit USD 10.82 Billion by 2034
February 18, 2025
·
1 min read
Press Releases
Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of the Society for Investigative Dermatology
April 23, 2025
·
8 min read
Genetown
Exsilio Therapeutics Launches with $82 Million Series A Financing to Develop Redosable Genomic Medicines for A Broad Range of Diseases
Exsilio Therapeutics, a biotechnology company developing genomic medicines for a broad range of diseases, announced its emergence from stealth with $82 million in Series A financing.
June 25, 2024
·
3 min read
Next Generation Bioprinting Market Expected to Grow at a CAGR of 29.82 % From 2024 to 2031
Global Next Generation Bioprinting Market is projected to record a CAGR of 29.82 % during the forecast period of 2024-2031.
May 8, 2024
·
4 min read
1 of 5,909
Next
